These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9835421)

  • 21. [Industrial production of monoclonal antibodies].
    Baron D
    Naturwissenschaften; 1990 Oct; 77(10):465-71. PubMed ID: 2280793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stable hybridoma cultivation in a pilot-scale acoustic perfusion system: long-term process performance and effect of recirculation rate.
    Dalm MC; Jansen M; Keijzer TM; van Grunsven WM; Oudshoorn A; Tramper J; Martens DE
    Biotechnol Bioeng; 2005 Sep; 91(7):894-900. PubMed ID: 15959892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in Monoclonal Antibody Production Using Various Bioreactor Syst.
    Jyothilekshmi I; Jayaprakash NS
    J Microbiol Biotechnol; 2021 Mar; 31(3):349-357. PubMed ID: 32238761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A hollow fibre dialysis system for the in vitro production of monoclonal antibodies replacing in vivo production in mice.
    Schönherr OT; van Gelder PT; van Hees PJ; van Os AM; Roelofs HW
    Dev Biol Stand; 1987; 66():211-20. PubMed ID: 3582749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of a quadroma and its parent hybridomas in fed batch culture.
    Salazar-Kish JM; Heath CA
    J Biotechnol; 1993 Sep; 30(3):351-65. PubMed ID: 7764111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of highly pure monoclonal antibodies without purification using a hollow fiber bioreactor.
    Kreutz FT; Jafarin A; Biggs DF; Suresh MR
    Hybridoma; 1997 Oct; 16(5):485-6. PubMed ID: 9388033
    [No Abstract]   [Full Text] [Related]  

  • 27. Statistical methods in media optimization for batch and fed-batch animal cell culture.
    De Alwis DM; Dutton RL; Scharer J; Moo-Young M
    Bioprocess Biosyst Eng; 2007 Mar; 30(2):107-13. PubMed ID: 17242929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoconstriction and the efficacy of hemoglobin-based blood substitutes.
    Winslow RM
    Transfus Clin Biol; 1994; 1(1):9-14. PubMed ID: 8186857
    [No Abstract]   [Full Text] [Related]  

  • 29. Continuous production of monoclonal antibody in a packed-bed bioreactor.
    Golmakany N; Rasaee MJ; Furouzandeh M; Shojaosadati SA; Kashanian S; Omidfar K
    Biotechnol Appl Biochem; 2005 Jun; 41(Pt 3):273-8. PubMed ID: 15506916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large-scale production of murine monoclonal antibodies using hollow fiber bioreactors.
    Evans TL; Miller RA
    Biotechniques; 1988 Sep; 6(8):762-7. PubMed ID: 3273638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current aspects in red blood cell substitutes].
    Wang Y; Pan J; Yu Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):490-4. PubMed ID: 15250164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic activity and monoclonal antibody production of Salmonella enteritidis O and H antigen specific hybridoma cells in static culture.
    Nalbantsoy A; Bora K; Deliloglu-Gurhan I
    Hybridoma (Larchmt); 2011 Apr; 30(2):189-93. PubMed ID: 21529293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perfusion cultures of hybridoma cells for monoclonal antibody production.
    Castillo FJ; Mullen LJ; Thrift JC; Grant BC
    Ann N Y Acad Sci; 1992 Oct; 665():72-80. PubMed ID: 1416621
    [No Abstract]   [Full Text] [Related]  

  • 34. Multi-rate nonlinear state and parameter estimation in a bioreactor.
    Tatiraju S; Soroush M; Mutharasan R
    Biotechnol Bioeng; 1999 Apr; 63(1):22-32. PubMed ID: 10099578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on monoclonal antibody production by a hybridoma cell line (C1E3) immobilised in a fixed bed, porosphere culture system.
    Racher AJ; Looby D; Griffiths JB
    J Biotechnol; 1990 Jul; 15(1-2):129-45. PubMed ID: 1366685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neohemoglobins as blood substitutes.
    Fronticelli C; Bucci E; Higgins N; Sassaroli M; Kowalczyk J
    Prog Clin Biol Res; 1983; 122():51-7. PubMed ID: 6878381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring of the production of monoclonal antibodies by hybridomas. Part I: Long-term cultivation in hollow fibre bioreactors using serum-free medium.
    van Erp R; Adorf M; van Sommeren AP; Schönherr OT; Gribnau TC
    J Biotechnol; 1991 Oct; 20(3):235-48. PubMed ID: 1367571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large-scale culture of hybridoma and mammalian cells in fluidized bed bioreactors.
    Dean RC; Karkare SB; Ray NG; Runstadler PW; Venkatasubramanian K
    Ann N Y Acad Sci; 1987; 506():129-46. PubMed ID: 3324851
    [No Abstract]   [Full Text] [Related]  

  • 39. A sensitivity analysis of the fed-batch animal-cell bioreactor with respect to some control parameters.
    Lavric V; Ofiţeru ID; Woinaroschy A
    Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):29-35. PubMed ID: 15270673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fractional factorial study of hybridoma behavior. 1. Kinetics of growth and antibody production.
    Gaertner JG; Dhurjati P
    Biotechnol Prog; 1993; 9(3):298-308. PubMed ID: 7763699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.